Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Salix Pharmaceuticals (SLXP) Starts Presentation at 25th Annual ROTH Conference

Posted on March 19, 2013 by Mission IR

Salix Pharmaceuticals develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. SLXP’s strategy is to in-license late-stage or marketed proprietary therapeutic drugs, complete any required development and regulatory submission of these products, and market these products through the company’s gastroenterology specialty sales and marketing team. For more information, visit the company’s Web site: http://www.salix.com

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *